Acute chest pain (ACP) is a common, yet challenging, clinical presentation that demands a systematic and efficient approach from healthcare professionals.
Initial evaluation should focus on ruling out life-threatening conditions such as acute coronary syndrome (ACS), pulmonary embolism, and aortic dissection. High index of suspicion, detailed history taking, physical examination, ECG, and biomarker analysis are crucial.
ECG is the first-line diagnostic tool. However, its sensitivity is limited. High-sensitivity troponin assays have improved the early diagnosis of ACS. Advanced imaging techniques like CT angiography offer high diagnostic accuracy.
Management strategies depend on the underlying cause. For ACS, immediate revascularization is the gold standard. Anticoagulation is the mainstay for pulmonary embolism, while surgical intervention is often required for aortic dissection.
ACP requires a systematic approach for evaluation, diagnosis, and management. Continuous education and staying updated with the latest evidence-based guidelines is essential for optimal patient care.
1.
NPM1-Mutated AML: Not All Treatments Are Equal
2.
Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey
3.
MRI can save rectal cancer patients from surgery, study suggests
4.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
5.
Rising rates of head and neck cancers in England
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
3.
Molecular Classification of Refractory Anemia: A Comprehensive Review
4.
Ferroptosis-Modulating Therapeutics in Precision Oncology
5.
Blood-Cell Morphology Foundation Models: Transforming Hematological Diagnostics and Clinical Practice
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Thromboprophylaxis In Medical Settings- An Update
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
How Platelet Disorders Can Affect the Body
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation